Bone marrow cells and rehabilitation for cerebral palsy in young children
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests whether transplanting cells from a child's own bone marrow, combined with rehabilitation therapy, can improve movement and function in young children with cerebral palsy caused by birth-related brain injury or bleeding. The goal is to see if this approach helps children move better and become more independent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 12 months and 6 years old
- Child has cerebral palsy (difficulty with movement and muscle control) caused by lack of oxygen or bleeding in the brain
- Child has moderate-to-severe movement limitations (GMFCS level III–V, meaning they need help with walking or cannot walk)
- Child has completed required blood work and health screening tests
- Child does not have an active infection, bleeding problems, or serious heart, liver, or kidney disease
- Child can participate in rehabilitation therapy sessions, and parents can give written permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting bone marrow cells can help children with spastic cerebral palsy caused by a lack of oxygen to the brain. It may improve movement and daily function.
This trial gives children with brain injuries an infusion of stem cells from their own or a sibling's umbilical cord blood, or from a matched donor. The goal is to see if these cells can help repair brain damage and improve function.
This trial tests a way to lower the risk of graft-versus-host disease (GVHD), a common complication after a bone marrow transplant, by removing certain immune cells from the donor's stem cells before giving them to the patient. It is for young children with non-cancerous blood or immune diseases who need a transplant.
This trial tests whether a single infusion of stem cells from donated umbilical or placental tissue is safe for people with cerebral palsy. It may help reduce symptoms, but the main goal is to check safety.
This trial tests giving stem cells through the nose to newborn babies who have brain injury from lack of oxygen or blood flow during birth. The goal is to reduce the risk of developing cerebral palsy.
This trial tests whether giving children with aplastic anemia a transplant using a matched unrelated donor (a bone marrow donor who is not a family member) can help treat their condition. It aims to see if this approach is effective and safe for children who qualify.
Hear when a new Cerebral Palsy Hypoxic-Ischemic Encephalopathy Intracranial Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.